Cubist Systematic Strategies LLC Invests $449,000 in Viemed Healthcare, Inc. (NASDAQ:VMD)

Cubist Systematic Strategies LLC purchased a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 55,965 shares of the company's stock, valued at approximately $449,000. Cubist Systematic Strategies LLC owned approximately 0.14% of Viemed Healthcare as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the business. BNP Paribas Financial Markets bought a new stake in shares of Viemed Healthcare in the 4th quarter valued at about $378,000. Ameriprise Financial Inc. bought a new position in shares of Viemed Healthcare during the 4th quarter worth approximately $340,000. Apis Capital Advisors LLC raised its stake in shares of Viemed Healthcare by 14.4% during the 4th quarter. Apis Capital Advisors LLC now owns 279,600 shares of the company's stock worth $2,242,000 after acquiring an additional 35,200 shares in the last quarter. PDT Partners LLC raised its stake in shares of Viemed Healthcare by 195.6% during the 4th quarter. PDT Partners LLC now owns 31,327 shares of the company's stock worth $251,000 after acquiring an additional 20,728 shares in the last quarter. Finally, Northern Trust Corp raised its stake in shares of Viemed Healthcare by 1.8% during the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock worth $2,300,000 after acquiring an additional 5,090 shares in the last quarter. Institutional investors own 74.24% of the company's stock.

Viemed Healthcare Stock Up 0.7%

Shares of NASDAQ VMD traded up $0.05 during trading hours on Tuesday, hitting $6.80. 160,894 shares of the stock were exchanged, compared to its average volume of 141,769. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. The company has a market cap of $268.76 million, a PE ratio of 25.19 and a beta of 1.49. The firm has a fifty day moving average price of $6.97 and a 200-day moving average price of $7.81. Viemed Healthcare, Inc. has a 12 month low of $6.14 and a 12 month high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. The firm had revenue of $59.10 million during the quarter, compared to analyst estimates of $60.60 million. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.